_1584093989590.png?format=webp&height=120&width=120){kind=logo}
About McKesson Ventures
McKesson Ventures is a venture capital firm founded in 2014. It is primarily based out of San Francisco, United States. As of May 2026, McKesson Ventures is an active investor, having invested in 38 companies, with 2 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series A round of BranchLab Overall, McKesson Ventures portfolio has seen 4 unicorns, 2 IPOs and 14 acquisitions including key companies like Accolade, Aledade and GRAIL. A lot of funds co-invest with McKesson Ventures, with names like Sanofi Ventures sharing a substantial percentage of its portfolio. McKesson Ventures has team of 8 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 4 more
Portfolio Unicorns
McKesson Ventures' List of Top Investments
McKesson Ventures has a portfolio of 38 companies, including 4 unicorns. Their most notable investments are in HarmonyCares and Truveris.Their portfolio spans across United States and United Kingdom. They have invested in HealthTech, Enterprise Applications, Life Sciences and 6 other sectors, across stages such as Series B, Series A and 4 more. Here is the list of top investments by McKesson Ventures:
1. Accolade
Cloud-based platform for employee health benefits. The platform provides consumer healthcare engagement and influence solutions for employers and payer organizations. The company offers a web portal and app-based health assistant to consumers which acts as a point of contact for health benefits or healthcare needs. It has features for users to engage in healthcare plans, access clinical guidance, access population health management, and compares benefits.
Key facts about Accolade
- Founded Year: 2007
- Location: Plymouth Meeting (United States)
- Annual Revenue: $414M as on Feb 29, 2024
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $228M
- Investors: Cross Creek, McKesson Ventures and 17 Others
- Latest Funding Round: Post IPO, Oct 15, 2021, $*****
- Highlight: Acquired
2. Aledade
Provider of primary care physician platform to deliver care for patients. The platform offers data analytics, guided workflows, healthcare policy expertise, and payer relationships for independent practices health centers, and clinics. It helps practioners and health centers optimize patient outcomes and generate revenue through value based care.
Key facts about Aledade
- Founded Year: 2014
- Location: Bethesda (United States)
- Valuation: $*****
- Stage: Series F
- Total Funding till date: $780M
- Employee Count: 1,815 as on Mar 31, 2026
- Investors: Meritech, Fidelity Investments and 18 Others
- Latest Funding Round: Conventional Debt, Dec 02, 2025, $*****
- Highlight: Editors' Pick
3. GRAIL
Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.
Key facts about GRAIL
- Founded Year: 2016
- Location: Menlo Park (United States)
- Annual Revenue: £32.8M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $2B
- Employee Count: 1,097 as on Apr 30, 2026
- Investors: Deep Track Capital, Gershon Capital and 51 Others
- Latest Funding Round: Post IPO, Oct 20, 2025, $*****
- Highlight: Public
AI and cloud-based platforms provide data-driven insights to healthcare providers. The company offers a healthcare map a proprietary tool that delivers patient-level insights by analyzing a broad range of data across patients and practitioners. It can be used for life sciences companies, healthcare practitioners, and payers.
Key facts about Komodo Health
- Founded Year: 2014
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $514M
- Employee Count: 753 as on Apr 30, 2026
- Investors: Dragoneer Investment Group, McKesson Ventures and 13 Others
- Latest Funding Round: Series E, Nov 2022, $*****
- Highlight: Editors' Pick
5. Amwell
Provider of telehealth and consultation solutions for doctors and patients. It allows users to communicate with doctors for urgent care such as online therapy, nutrition counseling, psychiatry services, and many more. It also provides solutions for bronchitis, flu, sinus infection, urinary tract infections, and others. Doctors can schedule telehealth appointments and provide consultation for patients.
Key facts about Amwell
- Founded Year: 2006
- Location: Boston (United States)
- Annual Revenue: $249M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $887M
- Employee Count: 923 as on Apr 30, 2026
- Investors: HTIF, McKesson Ventures and 25 Others
- Latest Funding Round: Series C, Aug 24, 2020, $*****
- Highlight: Public
McKesson Ventures' Year-on-Year Investment Trends
McKesson Ventures has invested in 38 companies over the last 11 years, with an average of 2 new investments annually in the last 10 years. As of May 2026, it has made 2 investments in this year. Its most recent first time investment was in BranchLab and most recent follow-on round was in IVX Health.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 0 | 0 | 0 |
2024 | 2 | 0 | 2 |
2023 | 0 | 0 | 0 |
2022 | 1 | 0 | 1 |
2021 | 3 | 1 | 4 |
2020 | 3 | 2 | 5 |
2019 | 3 | 1 | 4 |
2018 | 4 | 0 | 4 |
2017 | 2 | 1 | 3 |
McKesson Ventures' Investments by Stage
McKesson Ventures has made 12 investments in Series B stage with an average round size of $142M, 8 investments in Series A stage with an average round size of $15.7M and 5 investments in Series D stage with an average round size of $46.4M.Stage of entry | No. of Investments |
|---|---|
Series B | 12 |
Series A | 8 |
Series D | 5 |
Series C | 2 |
Post IPO | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
McKesson Ventures' Investments by Sector
McKesson Ventures has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Vertical SaaS, Life Sciences and Healthcare. Notably, it has invested in 33 Tech companies, 28 Enterprise (B2B) companies, 24 Software companies and at least 16 companies focusing on Saas.Sector | No. of Investments |
|---|---|
HealthTech | 21 |
Enterprise Applications | 14 |
Vertical SaaS | 9 |
Life Sciences | 8 |
Healthcare | 4 |
Others | 13 |
Note: We have considered here, only first round of investments
McKesson Ventures' Investments by Geography
McKesson Ventures has made most investments in United States (29).McKesson Ventures' recent investments
McKesson Ventures has made 2 investments in 2026 so far - BranchLab and Join Midi.Here are the most recent investments by McKesson Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 13, 2026 | United States | Series A | 8971 | [+2] | |
Feb 03, 2026 | United States | Series D | 9915 | [+7] | |
Dec 20, 2024 | United States | Series A | 2718 | [+15] | |
Jul 08, 2024 | United States | Unattributed | 8289 | [+5] | |
Jan 19, 2022 | United States | Series A | 7832 |
Unicorns in McKesson Ventures' Portfolio
McKesson Ventures has 4 unicorns in its portfolio - Join Midi, Komodo Health, Aledade and others. The most recent unicorn in their portfolio is Join Midi. It became a unicorn in 2026.Here is a list of unicorns in McKesson Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
64 | Provider of a virtual care platform focused on female midlife health | 2021 | Los Altos Hills | Series D | wqlbgzx | ||
71 | AI and cloud-based platforms provide data-driven insights to healthcare providers | 2014 | New York City | Series E | njnhpgt | ||
73 | Provider of primary care physician platform to deliver care for patients | 2014 | Bethesda | Series F | iornmae | ||
49 | E-commerce platform for pharmaceutical, nutritional and daily use products | 2011 | Hauppauge | Series D | xe{xdqt |
IPOs and Publicly Listed companies in McKesson Ventures' Portfolio
2 of McKesson Ventures' portfolio companies have become public. GRAIL got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2024 and Amwell got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $742M.Here are McKesson Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 25, 2024 | Feb 28, 2017 | Series B | 8019 | |
Sep 17, 2020 | - | - | 3129 |
Acquired companies in McKesson Ventures' Portfolio
14 companies from McKesson Ventures' portfolio have been acquired. The most recent acquisition was Aetion in May 2025 by Datavant for $*****.Here are McKesson Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 15, 2025 | Feb 05, 2019 | Series B | 7425 | |
Jan 08, 2025 | - | - | 4479 | |
Oct 02, 2024 | Dec 07, 2016 | Series B | 9035 | |
Oct 23, 2023 | Aug 24, 2021 | Series B | 9975 | |
May 09, 2022 | Nov 05, 2018 | Series B | 4521 |
Team profile of McKesson Ventures
McKesson Ventures has a team of 8 members located in United States. McKesson Ventures' team does not sit on the board of any company as of now.Co-investors of McKesson Ventures
Over the past 11 years, 244 investors have co-invested in McKesson Ventures's portfolio companies. This includes funds and angels.
- Invested before McKesson Ventures: Health Enterprise Partners, Google Ventures and 101 others have invested in rounds before McKesson Ventures. There are 3 companies where Health Enterprise Partners has invested before McKesson Ventures and 2 companies where Google Ventures has invested before McKesson Ventures.
- Top Co-investors of McKesson Ventures: 78 investors entered a company along with McKesson Ventures. These include investors like Sanofi Ventures (2 companies).
- Invested after McKesson Ventures: A total of 63 investors have invested in McKesson Ventures's portfolio after their investments. Top Investors include McKesson (4 companies), PSP Investments (1 company) and CPP Investments (1 company).
Recent News related to McKesson Ventures
•
Latent raised an $80M Series A co-led by Spark Capital and Transformation CapitalStock Screener•Apr 08, 2026•Transformation Capital, Latent AI, Spark Capital, Latent and 2 others
•
Midi Health Receives $100M Series D RoundMassinvestor•Feb 03, 2026•Join Midi, SemperVirens, Emerson Collective, Advance Venture Partners and 9 others
•
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences DealmakingBusiness Wire•Jan 07, 2026•McKesson Ventures, Prudentia Sciences, Virtue, Iaso Ventures and 3 others
•
Lumata Health Raises $23M in Series B FundingFinSMEs•Mar 05, 2025•Lumata Health, LRVHealth, McKesson Ventures, Cencora and 1 other
•
Healthcare payments firm Lynx scores $27 million funding roundFinextra•Feb 06, 2025•Flare Capital Partners, CVS Health Ventures, McKesson Ventures, .406 Ventures and 7 others
•
Bluenote Raises $10Million from Lux Capital & Elad Gil to Transform Life Sciences Workflows with AIAiThority•Dec 20, 2024•Bluenote AI, Lux Capital, Anthropic, Menlo Ventures and 5 others
•
Brooklyn Artificial Intelligence Research, the parent company of Brooklyn Investment Group, LLC, Announces Strategic Funding from Atypical Ventures, S&P Global, and Asset and Wealth Management ExecutivesPR Newswire•Dec 20, 2024•Brooklyn Artificial Intelligence Research, Atypical, S&P Global, Lux Capital and 5 others
•
HarmonyCares Secures $200M to Expand Access to In-Home Primary CarePR Newswire•Jul 08, 2024•HarmonyCares, General Catalyst, McKesson Ventures, K2 HealthVentures and 6 others
•
Atropos Health Raises $33M in Series B FundingGlobal Village Space•May 24, 2024•Atropos Health, McKesson, Merck, Cencora and 6 others
•
Atropos Health Lands $33m To Scale Ai-powered Real-world Evidence, Build Out Pharma PartnershipsFierce Healthcare•May 23, 2024•Atropos Health, Breyer Capital, Emerson Collective, Presidio Ventures and 7 others
